Total trials
289
Active
48
Phase 3
6
Total enrollment
58,148
Pipeline matrix
Showing 26 of 26 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Amoxicillin-clavulanate 875mg/125mg q12hrs | — | — | — | — | — | 1 | |
| oral clindamycin 300mg q6hrs | — | — | — | — | — | 1 | |
| Levofloxacin 750mg QID | — | — | — | — | — | 1 | |
| oral suzetrigine | — | — | — | — | — | 1 | |
| oral Oxycodone | — | — | — | — | — | 1 | |
| Bupivacaine | — | — | — | — | — | 1 | |
| Lidocaine 2% without vessel constrictor | — | — | — | — | — | 1 | |
| Povidone-Iodine | — | — | — | — | — | 1 | |
| Sterile water | — | — | — | — | — | 1 | |
| Normal Saline | — | — | — | — | — | 1 | |
| balanced crystalloid | — | — | — | — | — | 1 | |
| Metformin | — | — | — | — | — | 2 | |
| Nivolumab | — | — | — | — | — | 1 | |
| Palliative Radiation and Pembrolizumab | — | — | — | — | — | 1 | |
| Peppermint oil | — | — | — | — | — | 1 | |
| Coconut Oil | — | — | — | — | — | 1 | |
| Vemurafenib | — | — | — | — | — | 1 | |
| Proleukin and Dacarbazine | — | — | — | — | — | 1 | |
| Pembrolizumab | — | — | — | — | — | 1 | |
| Talimogene Laherparepvec | — | — | — | — | — | 1 | |
| : Placebo for Probiotic | — | — | — | — | — | 1 | |
| Temozolomide | — | — | — | — | — | 1 | |
| Gemcitabine | — | — | — | — | 2 | ||
| Folfirinox | — | — | — | — | 2 | ||
| Buspirone | — | — | — | — | — | 1 | |
| Immunotherapy | — | — | — | — | — | 1 |
Next readouts
- 2023-06
- 2025-05
- 2025-06
- 2025-06-01
- 2025-07-01
- 2025-08
- 2025-08-31
- 2025-11
- 2026-06-01
- 2026-07-31
Top conditions
- Spinal Cord Injuries14
- Gastroparesis6
- Asthma5
- Spinal Cord Injury5
- Eating Disorders5
- Anorexia Nervosa4
- Breast Cancer4
- Carcinoma, Non-Small Cell Lung4
Frequently asked questions about University of Louisville
- How many clinical trials does University of Louisville have on ClinicalTrials.gov?
- University of Louisville is listed as the lead sponsor on 289 clinical trials in ClinicalTrials.gov, 48 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Louisville's trials are in Phase 3?
- 6 of University of Louisville's trials are in Phase 3, spread across 26 active drug programs.
- What therapeutic areas does University of Louisville focus on?
- University of Louisville's most-studied conditions on ClinicalTrials.gov are Spinal Cord Injuries, Gastroparesis, Asthma, Spinal Cord Injury, Eating Disorders.
- When are University of Louisville's next clinical trial readouts?
- University of Louisville has 10 upcoming primary-completion readouts tracked here; the soonest is “Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome”, expected around 2023-06.